Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data
about
Management of inflammatory bowel disease in pregnancyInflammatory bowel diseases and human reproduction: a comprehensive evidence-based reviewRheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: A mixed-methods study.The safety of ketoprofen in different ages.Management of early aggressive rheumatoid arthritis during pregnancy and lactation.A safety assessment of tumor necrosis factor antagonists during pregnancy.Evolving knowledge of the teratogenicity of medications in human pregnancy.Safety of biologic therapy in rheumatoid arthritis.Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy.A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis.Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation.Drug safety in pregnant women and their babies: ignorance not bliss.Pregnancy outcome in women with autoimmune hepatitis.Human teratogens: update 2010.A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.
P2860
Q26865914-95B11C9B-4B58-4DB7-B538-359042084A03Q28388274-59F405EF-590F-4FCF-A80D-C56C16EA2356Q35415687-BF5E37B7-F497-48F1-BE9F-2A77373D1A80Q35749182-7413BBAA-F01F-4B13-8930-905FBF439A32Q37369689-58356551-5392-4259-8292-5F489B3BC222Q37510901-3E8BB61E-180F-4005-8B1D-A64C030836EDQ37724349-15277CF0-DE92-4702-BCC7-AFB16A17FF09Q37902132-2E9B2D5F-837D-47FF-B83E-6750F24A51DBQ37944433-955B8DEC-0DCD-44B8-BA98-575EA3E6B9ABQ38012490-D1599AD6-5894-40F5-8D20-E0556346501EQ38659766-4866A2C2-89FE-4EF6-AE98-8C0B402819FEQ38820088-1C92AA6C-5E8A-46FC-A381-195A83C60B8BQ46021985-E12020E1-235A-42F4-B324-AE25C5B076FCQ46330714-511B2BBE-D1C1-4EAD-B70B-3D71FAD30C3DQ51157618-7CDF6D58-AE73-4FF5-8F31-BAD6A8E1284DQ51715223-7190041D-AE68-4854-BE9D-9569B6F90FA8
P2860
Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human pregnancy safety for age ...... developing post-marketing data
@ast
Human pregnancy safety for age ...... developing post-marketing data
@en
type
label
Human pregnancy safety for age ...... developing post-marketing data
@ast
Human pregnancy safety for age ...... developing post-marketing data
@en
prefLabel
Human pregnancy safety for age ...... developing post-marketing data
@ast
Human pregnancy safety for age ...... developing post-marketing data
@en
P2093
P2860
P921
P356
P1476
Human pregnancy safety for age ...... developing post-marketing data
@en
P2093
Christina D Chambers
Diana Johnson
Kenneth L Jones
Zuhre N Tutuncu
P2860
P2888
P356
10.1186/AR1977
P577
2006-01-01T00:00:00Z
P5875
P6179
1011255472